Skip to content

Virtual Reality Mirror Therapy With Focused Object-Directed Attention System

Virtual Reality Mirror Therapy With Focused Object-Directed Attention for Neuro-Rehabilitation

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07525713
Enrollment
54
Registered
2026-04-13
Start date
2026-04-20
Completion date
2027-12-31
Last updated
2026-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Rehabilitation, Virtual Reality, Mirror Movement Therapy, Attention, Task Performance

Brief summary

In this study, we hypothesized that Virtual Reality Mirror Therapy with Focused Object-Directed Attention (VRMTFOA) would yield superior therapeutic effects compared to conventional Virtual Reality Mirror Therapy (VRMT) in individuals with unilateral stroke. The aim of this study is to compare the immediate effects of a single session of VRMT, VRMTFOA, and VRMTFOA with auditory feedback on upper extremity function and brain activity in stroke patients.

Interventions

Motor training targeted to goals that are relevant to the functional needs of the patient

Sponsors

National Cheng-Kung University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Clinical diagnosis of stroke with unilateral side involved; A score of Mini-mental state examination greater than 24 for proving higher mental function; Time of onset \> 6 months before treatment begins; and Premorbid right-handedness.

Exclusion criteria

* Severe vision impairment; Major cognitive-perceptual deficit; Other brain disease.

Design outcomes

Primary

MeasureTime frameDescription
Change in the result of Fugl-Meyer assessment (FMA) for motor function of upper extremity testbaseline, 9 weeks and 21 weeksEach item is rated on a three-point ordinal scale (2 points for the detail being performed completely, 1 point for the detail being performed partially, and 0 for the detail not being performed). The maximum motor performance score is 66 points for the upper extremity.

Secondary

MeasureTime frameDescription
Change in the result of Modified Ashworth scale (MAS)baseline, 9 weeks and 21 weeksMuscle tone is defined by assess muscle tone by evaluating resistance to passive stretch, reflecting the level of spasticity, with scores ranging from 0 (no increase in tone) to 4 (rigidity in flexion or extension).
Change in the result of Box and blocks testbaseline, 9 weeks and 21 weeksThe score is the number of blocks carried from one box to the other in one minute. Higher values represent a better outcome.
Change in the result of Semmes-Weinstein monofilament (SWM) testbaseline, 9 weeks and 21 weeksThe Semmes-Weinstein monofilamenttest examines the cutaneous pressure threshold, range from 1.65-6.65. Higher values represent a worse outcome.
Change in the result of Motor Activity Logbaseline, 9 weeks and 21 weeksSemi-structured interview examine how much and how well the subject uses their more-affected arm for 30 ADLs. Score range from 0-5. Higher values represent a better outcome.
Surface electromyography (sEMG)baseline, 9 weeksChange in the root mean square (RMS) of the EMG signal was computed to quantify the change of muscle activation.
Clinical Global Impression (CGI) scale9 weeksAssess overall clinical change, rated on a 7-point scale ranging from 1 (very much improved) to 7 (very much worse).

Countries

Taiwan

Contacts

CONTACTHsiu-Yun Hsu, Ph.D
hyhsu@mail.ncku.edu.tw886-6-2353535

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 14, 2026